CD8A and colorectal cancer: To test if the combination treatment enhances colorectal cancer cell sensitivity to CTLs, SW620 cells were irradiated (5 Gy) or treated with combination irradiation plus bortezomib prior to incubation with carcinoembryonic antigen (CEA)-specific CD8+ T cells.